/* SLIDE GALLERY FOR HOME PAGE */ /* SLIDE GALLERY FOR ABOUT CARDICA */


Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) Surgery

Article Links

Evaluation of PAS-PORT in CABG Surgery (EPIC)
The Journal of Thoracic and Cardiovascular Surgery

Twelve Month Patency with the PAS-Port Proximal Connector Device
A Single Center Prospective Randomized Trial

Six-Month Angiographic Follow-Up of the PAS-Port II Clinical Trial
The Annals of Thoracic Surgery

More Scientific Literature

Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) is a less invasive alternative to conventional coronary artery bypass graft (CABG) surgery. MIDCAB is performed through two to three small incisions (1" - 2" each) between the ribs while the heart is beating. By comparison, a traditional CABG procedure cuts through the sternum using one large incision (6" - 8") and requires the use of a heart-lung machine to divert blood during the procedure while the heart is stopped.

By using two to three small incisions, eliminating the use of the heart-lung machine, and operating on a beating heart, research shows that MIDCAB procedures provide the following patient advantages over conventional CABG surgery:

MIDCAB Procedure

Traditional CABG Procedure

  • Patients may be discharged in 2-3 days
  • Return to normal activities including driving in 2 weeks
  • Available to high risk patients when bypassing one to two coronary arteries
  • Patients may be discharged in 5-10 days
  • Return to normal activities including driving in 6-8 weeks
  • Available to low risk patients; recommended when bypassing three or more arteries

Cardica® PAS-Port® Proximal Anastomosis System
(PAS-Port system)


AesDex's PAS-Port system is a fully automated-device used to perform an anastomosis between a saphenous vein and the aorta during minimally-invasive or conventional, on- or off-pump CABG surgery. The PAS-Port system has been used in Japan and Europe since 2004, and received 510(k) clearance in the United States in 2008.

The PAS-Port system is designed to:

  • Eliminate aortic clamping and manipulation. Eliminating clamping may reduce the risk of particle release and ensuing neurocognitive events
  • Allow the surgeon to load the bypass graft and rapidly complete the anastomosis, typically in approximately one minute
  • Provide one-turn aortotomy and anastomosis
  • Reduce time required for anastomosis
  • Produce consistent, reproducible anastomoses, largely independent of surgical technique and skill set
  • Ensure secure graft attachment allowing for variable take-off angles
  • Leave no metal within the graft lumen
  • Be loaded into the system without damaging endothelial cells while maximizing the orifice, which is especially
    important in small grafts
  • Allow mechanically-governed repeatability and reduced procedural complexity
Pull Through
The bypass vessel graft is pulled through the PAS-Port system in preparation for deployment.
Eversion
The graft vessel is everted in preparation for deployment.
Poke Through
The vessel is prepared and ready to attach to the aorta.

PAS-Port System Met All Endpoints in Pivotal Trial

A 220-patient, prospective, pivotal, randomized trial of the PAS-Port® system was conducted at 12 sites in the United States and Europe. The trial compared venous bypass grafts to the aorta made using the PAS-Port system versus those made using conventional hand-sewn sutures. Results showed that the study met its primary endpoint of non-inferiority to hand-sewn anastomoses, as well as all other primary and secondary endpoints.

The results of the EPIC trial were published in the July 2009 issue of The Journal of Thoracic & Cardiovascular Surgery. To request a copy of the published report, click here.


Cardica® C-Port® Flex-A® Anastomosis System (Flex-A system)

 

The Flex-A system, with its flexible shaft, allows surgeons to perform vessel connections in areas of the heart that are difficult or impossible to reach using hand-sewn anastomoses.

The C-Port Flex-A system is designed to:

"Works on very small coronary arteries."

  • Improve quality, reliability and consistency of bypass graft connections
  • Reduce operating time and cost during MIDCAB procedures
  • Allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart
  • Facilitate minimally-invasive, closed-chest CABG surgery
  • Create compliant anastomoses in vessels greater than 1.3 millimeters in internal diameter

A clinical study demonstrated that 95% of the graft vessels studied following an anastomosis with the C-Port device were found to be open in angiograms performed at 6 months postoperatively. To view this study, click here.

For more information about the products, please contact AesDex, LLC.

 



With the acquisition of Dextera Surgical's assets, Cardica products are now manufactured by AesDex, LLC, and distributed by Aesculap.
> Read More
AesDex's stapling technology is designed to minimize operating time and to enable minimally-invasive and robot-assisted surgeries.
> Read More
Receive all the latest updates about AesDex
Share this website with your friends.